Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 3/20 | 0.31 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17976780 | 0.88 | PLA2G2A (0.35) | EPHX1PLA2G2A | |
| SCHEMBL15948706 | 0.88 | EPHX1 (0.37) | EPHX1CES2CTSKDAGLACNR1 | |
| SCHEMBL17976777 | 0.88 | S1PR1 (0.40) | — | |
| SCHEMBL15948786 | 0.81 | CTSK (0.37) | CTSKDAGLA | |
| SCHEMBL17174995 | 0.74 | CNR1 (0.36) | PLA2G2CCTSKDAGLACNR1PLA2G2A | |
| SCHEMBL17972403 | 0.74 | PLA2G2A (0.45) | PLA2G2CDAGLACNR1PLA2G2A | |
| SCHEMBL17972404 | 0.74 | PLA2G2A (0.44) | PLA2G2A | |
| SCHEMBL15685423 | 0.74 | EPHX1 (0.32) | EPHX1CTSKDAGLACNR1 | |
| SCHEMBL15685416 | 0.73 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL17174997 | 0.73 | DAGLA (0.37) | PLA2G2CDAGLACNR1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014124430-A1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2014-08-14 | — | — | WO | disclosed |